TRPA1 and gout: We previously implemented an artificial intelligence algorithm [30] and an in silico screening algorithm as drug repurposing tools for discovering new potential therapeutic solutions for MS, predicting that the antidepressant desvenlafaxine, antipsychotic paliperidone and gout medication febuxostat might act as TRPA1 antagonists [31].